-
市場
-
產品
-
資訊
-
Moo社區
-
課堂
-
查看更多
-
功能介紹
-
費用費用透明，無最低余額限制
投資選擇、功能介紹、費用相關信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 淺色
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
PR Newswire
CAESAREA, Israel, Oct. 11, 2021
CAESAREA, Israel, Oct. 11, 2021 /PRNewswire/ -- Fidmi Medical Ltd. (www.fidmimedical.com) has announced completion of a $2.2 million financing round and launched its FDA-cleared low-profile Percutaneous Endoscopic Gastrostomy (PEG) device in the U.S. Investors in the round include leading medical technology company Micro-Tech (Nanjing) Co., Ltd. (688029: Shanghai), The Trendlines Group (www.trendlines.com), (SGX: 42T) (OTCQX: TRNLY), and Agriline. Micro-Tech has been named Fidmi's exclusive distributor in the U.S. (www.mtendoscopy.com) and China.
Gastrostomy tubes, which help patients receive long-term nutritional support, are typically placed endoscopically and are replaced every 3-6 months. Complications such as clogging and dislodgement are common, resulting in inadequate nutrition and medication delivery, numerous tube replacements, and hospitalizations, all at substantial cost to patients and the health care system.
Within this $800 million market, Fidmi Medical's innovative low-profile gastrostomy system can be utilized for both initial placement and replacement and is more durable and comfortable for patients. Fidmi's improved low-profile gastrostomy tube has a replaceable inner tube that can easily be changed by patients without the assistance of medical professionals and a highly stable internal bumper that is resistant to accidental dislodgement. These features are expected to result in fewer complications, reducing healthcare costs for payers and healthcare systems. The Fidmi PEGs will provide a substantial improvement in quality of life for patients and their caregivers.
Fidmi Medical CEO Shahar Millis remarked, "We are truly excited to embark on the market entry phase for Fidmi. With FDA clearance and strategic collaboration with Micro-Tech, a leader in this field, we are well-positioned to make a real difference for people requiring long-term nutritional support."
"Together, we saw the opportunity to distribute a device that positively impacts patients and helps them get back to living their lives. We worked quickly to align on a distribution plan that allows the system to be accessible by more physicians -- meeting their needs for more efficient and higher quality patient care, all while tangibly reducing the cost," said Chris Li, President of Micro-Tech Endoscopy USA. "We are proud to partner with Fidmi and applaud their success in improving patient quality of life."
About Fidmi Medical
Fidmi Medical is an Israeli medical device company dedicated to developing enhanced feeding devices that offer easy insertion, replacement, and removal. Fidmi is a portfolio company of The Trendlines Group.
About Micro-Tech Endoscopy USA
Micro-Tech Endoscopy is focused on creating top-quality products for endoscopic diagnosis, and therapeutic medical devices that allow physicians to provide the highest level of care. By partnering with doctors dedicated to innovation, Micro-Tech is committed to bringing better devices to market, with unparalleled speed, at an economical price, and without the burden of contracts.
Contact:
Fidmi Medical
Shahar Millis, CEO, Fidmi Medical Ltd.
info@fidmimedical.com
+972-77-3628362
Micro-Tech Endoscopy USA, Inc.
Stephanie Reynolds / Emmie McMinn
stephanie.reynolds@trailrunnerint.com
emmie.mcminn@trailrunnerint.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fidmi-medical-launches-us-sales-of-novel-low-profile-peg-device-and-raises-2-2-million-301396871.html
SOURCE Fidmi Medical Ltd.
/Web site: https://www.fidmimedical.com
(END) Dow Jones Newswires
October 11, 2021 08:00 ET (12:00 GMT)
Press Release: Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
新聞稿：Fidmi Medical在美國推出新型低調PEG設備並籌集220萬美元
Fidmi Medical Launches U.S. Sales of Novel Low-Profile PEG Device and Raises $2.2 Million
Fidmi Medical在美國推出新型低調PEG設備並籌集220萬美元
PR Newswire
美通社
CAESAREA, Israel, Oct. 11, 2021
以色列凱撒利亞，2021年10月11日
CAESAREA, Israel, Oct. 11, 2021 /PRNewswire/ -- Fidmi Medical Ltd. (www.fidmimedical.com) has announced completion of a $2.2 million financing round and launched its FDA-cleared low-profile Percutaneous Endoscopic Gastrostomy (PEG) device in the U.S. Investors in the round include leading medical technology company Micro-Tech (Nanjing) Co., Ltd. (688029: Shanghai), The Trendlines Group (www.trendlines.com), (SGX: 42T) (OTCQX: TRNLY), and Agriline. Micro-Tech has been named Fidmi's exclusive distributor in the U.S. (www.mtendoscopy.com) and China.
亞洲網以色列凱撒利亞10月11日電Fidmi醫療有限公司(網址：www.fidmimedical.com)宣佈完成一輪220萬美元的融資，並在美國推出經食品和藥物管理局批准的低調經皮內窺鏡胃造口術設備。這輪融資的投資者包括領先的醫療技術公司微技(南京)有限公司(688029：上海)、趨勢線集團(www.trendlines.com)、(新加坡證券交易所市場代碼：42T)。Micro-Tech已被指定為Fidmi在美國(www.mtendosCopy.com)和中國的獨家經銷商。
Gastrostomy tubes, which help patients receive long-term nutritional support, are typically placed endoscopically and are replaced every 3-6 months. Complications such as clogging and dislodgement are common, resulting in inadequate nutrition and medication delivery, numerous tube replacements, and hospitalizations, all at substantial cost to patients and the health care system.
胃造瘻管幫助患者接受長期營養支持，通常放置在內窺鏡下，每3-6個月更換一次。堵塞和移位等併發症很常見，導致營養和藥物輸送不足、大量更換管子和住院，所有這些都給患者和衞生保健系統帶來了巨大的成本。
Within this $800 million market, Fidmi Medical's innovative low-profile gastrostomy system can be utilized for both initial placement and replacement and is more durable and comfortable for patients. Fidmi's improved low-profile gastrostomy tube has a replaceable inner tube that can easily be changed by patients without the assistance of medical professionals and a highly stable internal bumper that is resistant to accidental dislodgement. These features are expected to result in fewer complications, reducing healthcare costs for payers and healthcare systems. The Fidmi PEGs will provide a substantial improvement in quality of life for patients and their caregivers.
在這個8億美元的市場中，Fidmi Medical的創新低調胃造口術系統可以用於初始放置和替換，對患者來説更耐用和舒適。Fidmi改進的低調胃造口管有一個可更換的內管，患者無需醫療專業人員的幫助就可以很容易地更換內管，以及一個高度穩定的內部保險槓，可以防止意外移位。這些功能預計將減少併發症，降低支付者和醫療系統的醫療成本。Fidmi釘子將大大提高患者及其照顧者的生活質量。
Fidmi Medical CEO Shahar Millis remarked, "We are truly excited to embark on the market entry phase for Fidmi. With FDA clearance and strategic collaboration with Micro-Tech, a leader in this field, we are well-positioned to make a real difference for people requiring long-term nutritional support."
Fidmi Medical首席執行官沙哈爾·米利斯説：“我們真的很高興能進入Fidmi的市場進入階段。有了FDA的批准以及與該領域的領先者Micro-Tech的戰略合作，我們處於有利地位，能夠為需要長期營養支持的人帶來真正的不同。”
"Together, we saw the opportunity to distribute a device that positively impacts patients and helps them get back to living their lives. We worked quickly to align on a distribution plan that allows the system to be accessible by more physicians -- meeting their needs for more efficient and higher quality patient care, all while tangibly reducing the cost," said Chris Li, President of Micro-Tech Endoscopy USA. "We are proud to partner with Fidmi and applaud their success in improving patient quality of life."
美國微技內窺鏡公司總裁克里斯·李説：“我們一起看到了分銷一種對患者產生積極影響並幫助他們重新開始生活的設備的機會。我們迅速制定了一項分銷計劃，讓更多的醫生能夠使用該系統，滿足了他們對更高效、更高質量的患者護理的需求，同時切實降低了成本，”美國微技內窺鏡公司總裁克里斯·李(Chris Li)説。我們為能與Fidmi合作感到自豪，併為他們在提高患者生活質量方面取得的成功而喝彩。“
About Fidmi Medical
關於菲德米醫療公司
Fidmi Medical is an Israeli medical device company dedicated to developing enhanced feeding devices that offer easy insertion, replacement, and removal. Fidmi is a portfolio company of The Trendlines Group.
Fidmi Medical是一家以色列醫療設備公司，致力於開發易於插入、更換和取出的增強型餵養設備。Fidmi是Trendines Group的投資組合公司。
About Micro-Tech Endoscopy USA
關於MicroTech內窺鏡檢查使用情況
Micro-Tech Endoscopy is focused on creating top-quality products for endoscopic diagnosis, and therapeutic medical devices that allow physicians to provide the highest level of care. By partnering with doctors dedicated to innovation, Micro-Tech is committed to bringing better devices to market, with unparalleled speed, at an economical price, and without the burden of contracts.
微技內窺鏡專注於為內窺鏡診斷和治療性醫療設備創造高質量的產品，使醫生能夠提供最高水平的護理。通過與致力於創新的醫生合作，Micro-Tech致力於以無與倫比的速度、經濟的價格和沒有合同負擔的方式將更好的設備推向市場。
Contact:
聯繫方式：
Fidmi Medical
菲德米醫療
Shahar Millis, CEO, Fidmi Medical Ltd.
Shahar Millis，Fidmi Medical Ltd.首席執行官。
info@fidmimedical.com
郵箱：info@fidmimedical.com
+972-77-3628362
+972-77-3628362
Micro-Tech Endoscopy USA, Inc.
美國微科內窺鏡公司。
Stephanie Reynolds / Emmie McMinn
斯蒂芬妮·雷諾茲/艾米·麥克明
stephanie.reynolds@trailrunnerint.com
郵箱：stephanie.reynolds@trailrunnerint.com
emmie.mcminn@trailrunnerint.com
郵箱：emmie.mcminn@trailrunnerint.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/fidmi-medical-launches-us-sales-of-novel-low-profile-peg-device-and-raises-2-2-million-301396871.html
查看原創內容以下載multimedia:https://www.prnewswire.com/news-releases/fidmi-medical-launches-us-sales-of-novel-low-profile-peg-device-and-raises-2-2-million-301396871.html
SOURCE Fidmi Medical Ltd.
來源：Fidmi Medical Ltd.
/Web site: https://www.fidmimedical.com
網址：https://www.fidmimedical.com
(END) Dow Jones Newswires
(完)道瓊通訊社
October 11, 2021 08:00 ET (12:00 GMT)
2021年10月11日東部時間08：00(格林尼治標準時間12：00)
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
風險及免責聲明
moomoo是Moomoo Technologies Inc.公司提供的金融資訊和交易應用程式。
在美國，moomoo上的投資產品和服務由Moomoo Financial Inc.提供，一家受美國證券交易委員會（SEC）監管的持牌主體。 Moomoo Financial Inc.是金融業監管局（FINRA）和證券投資者保護公司（SIPC）的成員。
在新加坡，moomoo上的投資產品和服務是通過Moomoo Financial Singapore Pte. Ltd.提供，該公司受新加坡金融管理局（MAS）監管(牌照號碼︰CMS101000) ，持有資本市場服務牌照 (CMS) ，持有財務顧問豁免（Exempt Financial Adviser）資質。本內容未經新加坡金融管理局的審查。
在澳大利亞，moomoo上的金融產品和服務是通過Futu Securities (Australia) Ltd提供，該公司是受澳大利亞證券和投資委員會(ASIC)監管的澳大利亞金融服務許可機構（AFSL No. 224663）。請閱讀並理解我們的《金融服務指南》、《條款與條件》、《隱私政策》和其他披露文件，這些文件可在我們的網站 https://www.moomoo.com/au中獲取。
在加拿大，透過moomoo應用程式提供的僅限訂單執行的券商服務由Moomoo Financial Canada Inc.提供，並受加拿大投資監管機構（CIRO）監管。
在馬來西亞，moomoo上的投資產品和服務是透過Moomoo Securities Malaysia Sdn. Bhd. 提供，該公司受馬來西亞證券監督委員會（SC）監管(牌照號碼︰eCMSL/A0397/2024) ，持有資本市場服務牌照 (CMSL) 。本內容未經馬來西亞證券監督委員會的審查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd.，Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc和Moomoo Securities Malaysia Sdn. Bhd., 是關聯公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用瀏覽器的分享功能，分享給你的好友吧